MicroRNA-based strategy to mitigate the risk of gain-of-function influenza studies

A strategy exploiting species-specific miRNA expression may provide another layer of biosafety in gain-of-function influenza experiments. Recent gain-of-function studies in influenza A virus H5N1 strains revealed that as few as three-amino-acid changes in the hemagglutinin protein confer the capacit...

Full description

Saved in:
Bibliographic Details
Published in:Nature biotechnology Vol. 31; no. 9; pp. 844 - 847
Main Authors: Langlois, Ryan A, Albrecht, Randy A, Kimble, Brian, Sutton, Troy, Shapiro, Jillian S, Finch, Courtney, Angel, Matthew, Chua, Mark A, Gonzalez-Reiche, Ana Silvia, Xu, Kemin, Perez, Daniel, García-Sastre, Adolfo, tenOever, Benjamin R
Format: Journal Article
Language:English
Published: New York Nature Publishing Group US 01-09-2013
Nature Publishing Group
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:A strategy exploiting species-specific miRNA expression may provide another layer of biosafety in gain-of-function influenza experiments. Recent gain-of-function studies in influenza A virus H5N1 strains revealed that as few as three-amino-acid changes in the hemagglutinin protein confer the capacity for viral transmission between ferrets 1 , 2 . As transmission between ferrets is considered a surrogate indicator of transmissibility between humans, these studies raised concerns about the risks of gain-of-function influenza A virus research. Here we present an approach to strengthen the biosafety of gain-of-function influenza experiments. We exploit species-specific endogenous small RNAs to restrict influenza A virus tropism. In particular, we found that the microRNA miR-192 was expressed in primary human respiratory tract epithelial cells as well as in mouse lungs but absent from the ferret respiratory tract. Incorporation of miR-192 target sites into influenza A virus did not prevent influenza replication and transmissibility in ferrets, but did attenuate influenza pathogenicity in mice. This molecular biocontainment approach should be applicable beyond influenza A virus to minimize the risk of experiments involving other pathogenic viruses.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
ISSN:1087-0156
1546-1696
DOI:10.1038/nbt.2666